US approves new drug to treat Alzheimer's disease
WASHINGTON, United States - The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. (FILES) This file photo taken on March 18, 2017, shows a sign for biotechnology company Bi